Ident. | Authors (with country if any) | Title |
---|
000069 (2012) |
Naomi Schlesinger [États-Unis] ; Rieke E. Alten [Allemagne] ; Thomas Bardin [France] ; H Ralph Schumacher [États-Unis] ; Mark Bloch [Australie] ; Alberto Gimona [Suisse] ; Gerhard Krammer [Suisse] ; Valda Murphy [Suisse] ; Dominik Richard [Suisse] ; Alexander K. So [Suisse] | Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions |
000128 (2010) |
Mark A. Rosenthal [Australie] ; Peter Davidson [Nouvelle-Zélande] ; Frederic Rolland [France] ; Mario Campone [France] ; Lingling Xue [États-Unis] ; Tae H. Han [États-Unis] ; Anish Mehta [États-Unis] ; Yuliya Berd [États-Unis] ; Weili He [États-Unis] ; Antonio Lombardi [États-Unis] | Evaluation of the safety, pharmacokinetics and treatment effects of an ανβ3 integrin inhibitor on bone turnover and disease activity in men with hormone‐refractory prostate cancer and bone metastases |
000265 (2011) |
Chris G. Mcmahon [Australie] ; Stanley E. Althof [États-Unis] ; Joel M. Kaufman [États-Unis] ; Jacques Buvat [France] ; Stephen B. Levine [États-Unis] ; Joseph W. Aquilina [États-Unis] ; Fisseha Tesfaye [États-Unis] ; Margaret Rothman [États-Unis] ; David A. Rivas [États-Unis] ; Hartmut Porst [Allemagne] | Efficacy and Safety of Dapoxetine for the Treatment of Premature Ejaculation: Integrated Analysis of Results from Five Phase 3 Trials |
000293 (2005) |
H. Toplak [Autriche] ; O. Ziegler [France] ; U. Keller [Suisse] ; A. Hamann [Allemagne] ; C. Godin [Canada] ; G. Wittert [Australie] ; M. Zanella [Brésil] ; S. Zú Iga-Guajardo [Mexique] ; L. Van Gaal [Belgique] | X‐PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced‐energy diet. Early response to treatment predicts weight maintenance |
000617 (2008) |
D. M. Reid [Royaume-Uni] ; D. Hosking [Royaume-Uni] ; D. Kendler [Canada] ; M. L. Brandi [Italie] ; J. D. Wark [Australie] ; J. F. Marques-Neto [Brésil] ; G. Weryha [France] ; N. Verbruggen [États-Unis] ; C. M. Hustad [États-Unis] ; E. M. Mahlis [États-Unis] ; M. E. Melton [États-Unis] | A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24‐month results from FACTS‐International |
000626 (2000) |
Eric J. Topola ; J. Donald Eastonb ; Pierre Amarencoc ; Robert Califfd ; Robert Harringtond ; Carmen Graffagninod ; Stephen Davise ; H. C. Dienerf ; James Fergusong ; Desmond Fitzgeraldh ; Ashfaq Shuaibi ; Peter J. Koudstaalj ; Pierre Therouxk ; Frans Van De Werfl ; James T. Willersonm ; Robert Chann ; Robert Samuelsn ; Bernard Ilsonn ; Jeffrey Granettn | Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial |
000687 (2005) |
Marcus D. Flather [Royaume-Uni] ; Marcelo C. Shibata [Royaume-Uni, Canada] ; Andrew J. S. Coats [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Aleksandr Parkhomenko [Ukraine] ; Joszef Borbola [Hongrie] ; Alain Cohen-Solal [France] ; Dan Dumitrascu [Roumanie] ; Roberto Ferrari [Italie] ; Philippe Lechat [France] ; Jordi Soler-Soler [Espagne] ; Luigi Tavazzi [Italie] ; Lenka Spinarova [République tchèque] ; Jiri Toman [République tchèque] ; Michael Bo Hm [Allemagne] ; Stefan D. Anker [Allemagne] ; Simon G. Thompson [Royaume-Uni] ; Philip A. Poole-Wilson [Royaume-Uni] | Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) |
000769 (2000) |
Robert A. De Man ; Patrick Marcellin ; Flavio Habal ; Paul Desmond ; Teresa Wright ; Toby Rose ; Regina Jurewicz ; Clarence Young | A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen–positive hepatitis B |
000779 (2003) |
Howard Feldman [Canada] ; Serge Gauthier [Canada] ; Jane Hecker [Australie] ; Bruno Vellas [France] ; Birol Emir ; Vera Mastey ; Ponni Subbiah [États-Unis] ; Ponni The Donepezil Msad Study Investigators Group [Canada] | Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden |
000B14 (2005) |
Howard Feldman [Canada] ; Serge Gauthier [Canada] ; Jane Hecker [Australie] ; Bruno Vellas [France] ; Yikang Xu [États-Unis] ; John R. Ieni [États-Unis] ; Elias M. Schwam [États-Unis] | Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo‐controlled trial |
001197 (1995) |
J. W. W. Studd [Royaume-Uni] ; K. Mccarthy [Royaume-Uni] ; D. Zamblera [Royaume-Uni] ; H. G. Burger [Australie] ; S. Silberberg [Australie] ; B. Wren [Australie] ; M. P. Dain [France] ; L. Le Lann [France] ; C. Vandepol [États-Unis] | Efficacy and tolerance of Menorest® compared to Premarin® in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy study |
001354 (2005) |
A. B. Gottlieb [Suisse] ; C. E. M. Griffiths [Suisse] ; V. C. Ho [Suisse] ; M. Lahfa [Suisse] ; U. Mrowietz [Suisse] ; D. F. Murrell [Suisse] ; J-P. Ortonne [Suisse] ; G. Todd [Suisse] ; R. Cherill [Suisse] ; I. Marks [Suisse] ; S. Emady-Azar [Suisse] ; C. F. Paul [Suisse] | Oral pimecrolimus in the treatment of moderate to severe chronic plaque‐type psoriasis: a double‐blind, multicentre, randomized, dose‐finding trial |
001773 (2006) |
Wolfram Sterry [Allemagne] ; Georg Stingl [Autriche] ; Richard G. B. Langley [Canada] ; Hugh Zacharie [Danemark] ; Morad Lahfa [France] ; Alberto Giannetti [Italie] ; Carlos Ferrándiz [Espagne] ; Rodney Sinclair [Australie] ; Jean-Hilaire Saurat [Suisse] | CLinical Experience Acquired with Raptiva® (CLEAR) trial in patients with moderate‐to‐severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo‐controlled trial |
001E65 (2006) |
L. Dubertret ; W. Sterry ; J. D. Bos ; S. Chimenti ; S. Shumack ; C. G. Larsen ; N. H. Shear ; K. A. Papp | CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate‐to‐severe plaque psoriasis: results from a phase III international randomized, placebo‐controlled trial |
001F14 (2000) |
Kennedy R. Lees [Royaume-Uni] ; Kjell Asplund [Suède] ; Antonio Carolei [Italie] ; Stephen M. Davis [Australie] ; Hans-Christoph Diener [Allemagne] ; Markku Kaste [Finlande] ; Jean-Marc Orgogozo [France] ; John Whitehead [Royaume-Uni] | Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial |
002232 (2006) |
Christine Jenkins [Australie] ; Renata Kolarikova ; Piotr Kuna ; Denis Caillaud ; Joaquin Sanchis ; Wolfgang Popp ; Eva Pettersson [Suède] | Efficacy and safety of high‐dose budesonide/formoterol (Symbicort®) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma |
002370 (2012) |
Bertram Pitt [États-Unis] ; Gerasimos Filippatos [Grèce] ; Mihai Gheorghiade [États-Unis] ; Lars Kober [Danemark] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Christina Nowack [Allemagne] ; Peter Kolkhof [Allemagne] ; So-Young Kim [Allemagne] ; Faiez Zannad [France] | Rationale and design of ARTS: a randomized, double‐blind study of BAY 94‐8862 in patients with chronic heart failure and mild or moderate chronic kidney disease |
002426 (1998) |
Mam Bomhof [Pays-Bas, Australie, France, Royaume-Uni] ; J. Heywood [Pays-Bas, Australie, France, Royaume-Uni] ; A. Pradalier [Pays-Bas, Australie, France, Royaume-Uni] ; H. Enahoro [Pays-Bas, Australie, France, Royaume-Uni] ; P. Winter [Pays-Bas, Australie, France, Royaume-Uni] ; H. Hassani [Pays-Bas, Australie, France, Royaume-Uni] | Tolerability and Efficacy of Naratriptan Tablets with Long-Term Treatment (6 Months) |
002A10 (2004) |
Ronnie Willenheimer [Suède] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Bernard Silke [Irlande (pays)] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Louis Van De Ven [Allemagne] ; Patricia Verkenne [Allemagne] ; Philippe Lechat [France] | Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS‐III |
002C13 (2013) |
Joachim Sieper [Allemagne] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France] ; Philip J. Mease [États-Unis] ; Walter P. Maksymowych [Canada] ; Matthew A. Brown [Australie] ; Vipin Arora [États-Unis] ; Aileen L. Pangan [États-Unis] | Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1) |